Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A genome-wide association study identifies two new risk loci for Graves' disease.

Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, Zhang XM, Yuan GY, Li CG, Xue LQ, Shen M, Liu W, Xie F, Yang SY, Wang HF, Shi JY, Sun WW, Du WH, Zuo CL, Shi JX, Liu BL, Guo CC, Zhan M, Gu ZH, Zhang XN, Sun F, Wang ZQ, Song ZY, Zou CY, Sun WH, Guo T, Cao HM, Ma JH, Han B, Li P, Jiang H, Huang QH, Liang L, Liu LB, Chen G, Su Q, Peng YD, Zhao JJ, Ning G, Chen Z, Chen JL, Chen SJ, Huang W, Song HD; China Consortium for Genetics of Autoimmune Thyroid Disease.

Nat Genet. 2011 Aug 14;43(9):897-901. doi: 10.1038/ng.898.

PMID:
21841780
2.

Association of 4p14 and 6q27 variation with Graves disease: a case-control study and a meta-analysis of available evidence.

Li FM, Liu L, Pang LN, Shen M, Lu HW, Zhang XH, Chu X, Song ZJ.

BMC Med Genet. 2017 May 18;18(1):56. doi: 10.1186/s12881-017-0406-7.

3.

Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.

McLachlan SM, Aliesky HA, Chen CR, Williams RW, Rapoport B.

PLoS One. 2011;6(6):e21378. doi: 10.1371/journal.pone.0021378. Epub 2011 Jun 27.

4.

Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.

Gu LQ, Zhu W, Zhao SX, Zhao L, Zhang MJ, Cui B, Song HD, Ning G, Zhao YJ.

Clin Endocrinol (Oxf). 2010 Feb;72(2):248-55. doi: 10.1111/j.1365-2265.2009.03617.x. Epub 2009 Apr 27.

PMID:
19438904
5.

The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves' disease in a Polish Caucasian population.

Szymański K, Bednarczuk T, Krajewski P, Płoski R.

Tissue Antigens. 2012 May;79(5):380-3. doi: 10.1111/j.1399-0039.2012.01854.x.

PMID:
22489947
6.

Pooled genome wide association detects association upstream of FCRL3 with Graves' disease.

Khong JJ, Burdon KP, Lu Y, Laurie K, Leonardos L, Baird PN, Sahebjada S, Walsh JP, Gajdatsy A, Ebeling PR, Hamblin PS, Wong R, Forehan SP, Fourlanos S, Roberts AP, Doogue M, Selva D, Montgomery GW, Macgregor S, Craig JE.

BMC Genomics. 2016 Nov 18;17(1):939.

7.

Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.

Yin X, Latif R, Bahn R, Tomer Y, Davies TF.

Thyroid. 2008 Nov;18(11):1201-6. doi: 10.1089/thy.2008.0098.

8.

The replication of the association of the rs9355610 within 6p27 with Graves' disease.

Ban Y, Tozaki T, Taniyama M.

Autoimmunity. 2013 Sep;46(6):395-8. doi: 10.3109/08916934.2013.780600.

PMID:
24001206
9.

Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.

Morgenthaler NG, Hodak K, Seissler J, Steinbrenner H, Pampel I, Gupta M, McGregor AM, Scherbaum WA, Banga JP.

Thyroid. 1999 May;9(5):466-75.

PMID:
10365678
10.

Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice.

Rapoport B, Williams RW, Chen CR, McLachlan SM.

Genes Immun. 2010 Apr;11(3):254-63. doi: 10.1038/gene.2010.8.

11.

Thyroid-stimulating hormone receptor and its role in Graves' disease.

Chistiakov DA.

Mol Genet Metab. 2003 Dec;80(4):377-88. Review.

PMID:
14654350
13.

TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.

Bufalo NE, Dos Santos RB, Marcello MA, Piai RP, Secolin R, Romaldini JH, Ward LS.

J Endocrinol Invest. 2015 May;38(5):555-61. doi: 10.1007/s40618-014-0228-9. Epub 2014 Dec 28.

PMID:
25543543
14.

The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.

Jaspan JB, Sullivan K, Garry RF, Lopez M, Wolfe M, Clejan S, Yan C, Tenenbaum S, Sander DM, Ahmed B, Bryer-Ash M.

J Clin Endocrinol Metab. 1996 Jun;81(6):2271-9.

PMID:
8964863
15.

Current insights into animal models of Graves' disease and orbitopathy.

Wiesweg B, Johnson KT, Eckstein AK, Berchner-Pfannschmidt U.

Horm Metab Res. 2013 Aug;45(8):549-55. doi: 10.1055/s-0033-1343451. Epub 2013 Apr 23. Review.

PMID:
23613015
16.

A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.

Giuliani C, Cerrone D, Harii N, Thornton M, Kohn LD, Dagia NM, Fiore E, Bucci I, Chamblin T, Vitti P, Monaco F, Napolitano G.

J Clin Endocrinol Metab. 2012 Jul;97(7):E1106-15. doi: 10.1210/jc.2011-2893. Epub 2012 Apr 10.

PMID:
22496495
17.

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.

Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ, Wiersinga WM, Hegedüs L, Connell J, Wass JA, Franklyn JA, Weetman AP, Heward JM, Gough SC.

Hum Mol Genet. 2009 May 1;18(9):1704-13. doi: 10.1093/hmg/ddp087. Epub 2009 Feb 25.

PMID:
19244275
18.
19.

A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.

Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M.

J Immunol. 2002 Mar 15;168(6):2789-94.

20.

Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population.

Liu BL, Yang SY, Liu W, Xue LQ, Chen X, Pan CM, Gu ZH, Zhan M, Zhang XM, Liang J, Gao GQ, Du WH, Yuan GY, Ying R, Zhao SX, Song HD.

Eur J Endocrinol. 2014 Jan 1;170(1):109-19. doi: 10.1530/EJE-13-0517. Print 2014 Jan.

Supplemental Content

Support Center